Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug Screening

被引:0
作者
Becker, Pamela S. [1 ,2 ,3 ]
机构
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Natl Med Ctr, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Hematol Malignancies Translat Sci, Beckman Res Inst, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源
BLOOD CANCER DISCOVERY | 2023年 / 4卷 / 06期
关键词
OLDER PATIENTS;
D O I
10.1158/2643-3230.BCD-23-0180
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High-throughput screens (HTS) have been utilized to assess the efficacy of single drugs against patient tumor samples with the purpose of optimizing precision therapy, but testing the synergy of drug combinations can identify the ideal second drug to add. With novel sophisticated HTS, effective venetoclax combinations can be revealed that provide the cell state, phenotype, and molecular features of the susceptible and resistant cell populations.
引用
收藏
页码:437 / 439
页数:3
相关论文
共 13 条
[1]   Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia [J].
Cashen, Amanda F. ;
Schiller, Gary J. ;
O'Donnell, Margaret R. ;
DiPersio, John F. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :556-561
[2]   Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia [J].
DiNardo, Courtney D. ;
Pratz, Keith ;
Pullarkat, Vinod ;
Jonas, Brian A. ;
Arellano, Martha ;
Becker, Pamela S. ;
Frankfurt, Olga ;
Konopleva, Marina ;
Wei, Andrew H. ;
Kantarjian, Hagop M. ;
Xu, Tu ;
Hong, Wan-Jen ;
Chyla, Brenda ;
Potluri, Jalaja ;
Pollyea, Daniel A. ;
Letai, Anthony .
BLOOD, 2019, 133 (01) :7-17
[3]   International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts [J].
Dombret, Herve ;
Seymour, John F. ;
Butrym, Aleksandra ;
Wierzbowska, Agnieszka ;
Selleslag, Dominik ;
Jang, Jun Ho ;
Kumar, Rajat ;
Cavenagh, James ;
Schuh, Andre C. ;
Candoni, Anna ;
Recher, Christian ;
Sandhu, Irwindeep ;
Bernal del Castillo, Teresa ;
Al-Ali, Haifa Kathrin ;
Martinelli, Giovanni ;
Falantes, Jose ;
Noppeney, Richard ;
Stone, Richard M. ;
Minden, Mark D. ;
McIntyre, Heidi ;
Songer, Steve ;
Lucy, Lela M. ;
Beach, C. L. ;
Doehner, Hartmut .
BLOOD, 2015, 126 (03) :291-299
[4]   Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy [J].
Eide, Christopher A. ;
Kurtz, Stephen E. ;
Kaempf, Andy ;
Long, Nicola ;
Joshi, Sunil Kumar ;
Nechiporuk, Tamilla ;
Huang, Ariane ;
Dibb, Charles A. ;
Taylor, Akosha ;
Bottomly, Daniel ;
Mcweeney, Shannon K. ;
Minnier, Jessica ;
Lachowiez, Curtis A. ;
Saultz, Jennifer N. ;
Swords, Ronan T. ;
Agarwal, Anupriya ;
Chang, Bill H. ;
Druker, Brian J. ;
Tyner, Jeffrey W. .
BLOOD CANCER DISCOVERY, 2023, 4 (06) :452-467
[5]   The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity [J].
Holbeck, Susan L. ;
Camalier, Richard ;
Crowell, James A. ;
Govindharajulu, Jeevan Prasaad ;
Hollingshead, Melinda ;
Anderson, Lawrence W. ;
Polley, Eric ;
Rubinstein, Larry ;
Srivastava, Apurva ;
Wilsker, Deborah ;
Collins, Jerry M. ;
Doroshow, James H. .
CANCER RESEARCH, 2017, 77 (13) :3564-3576
[6]   Bipartite network models to design combination therapies in acute myeloid leukaemia [J].
Jafari, Mohieddin ;
Mirzaie, Mehdi ;
Bao, Jie ;
Barneh, Farnaz ;
Zheng, Shuyu ;
Eriksson, Johanna ;
Heckman, Caroline A. ;
Tang, Jing .
NATURE COMMUNICATIONS, 2022, 13 (01)
[7]   Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia [J].
Kuusanmaki, Heikki ;
Kytola, Sari ;
Vanttinen, Ida ;
Ruokoranta, Tanja ;
Ranta, Amanda ;
Huuhtanen, Jani ;
Suvela, Minna ;
Parsons, Alun ;
Holopainen, Annasofia ;
Partanen, Anu ;
Kuusisto, Milla E. L. ;
Koskela, Sirpa ;
Raty, Riikka ;
Itala-Remes, Maija ;
Vastrik, Imre ;
Dufva, Olli ;
Siitonen, Sanna ;
Porkka, Kimmo ;
Wennerberg, Krister ;
Heckman, Caroline A. ;
Ettala, Pia ;
Pyorala, Marja ;
Rimpilainen, Johanna ;
Siitonen, Timo ;
Kontro, Mika .
HAEMATOLOGICA, 2023, 108 (07) :1768-1781
[8]   Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia [J].
Kuusanmaki, Heikki ;
Leppa, Aino-Maija ;
Polonen, Petri ;
Kontro, Mika ;
Dufva, Olli ;
Deb, Debashish ;
Yadav, Bhagwan ;
Bruck, Oscar ;
Kumar, Ashwini ;
Everaus, Hele ;
Gjertsen, Bjorn T. ;
Heinaniemi, Merja ;
Porkka, Kimmo ;
Mustjoki, Satu ;
Heckman, Caroline A. .
HAEMATOLOGICA, 2020, 105 (03) :708-720
[9]   Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia [J].
Malani, Disha ;
Kumar, Ashwini ;
Bruck, Oscar ;
Kontro, Mika ;
Yadav, Bhagwan ;
Hellesoy, Monica ;
Kuusanmaki, Heikki ;
Dufva, Olli ;
Kankainen, Matti ;
Eldfors, Samuli ;
Potdar, Swapnil ;
Saarela, Jani ;
Turunen, Laura ;
Parsons, Alun ;
Vastrik, Imre ;
Kivinen, Katja ;
Saarela, Janna ;
Raty, Riikka ;
Lehto, Minna ;
Wolf, Maija ;
Gjertsen, Bjorn Tore ;
Mustjoki, Satu ;
Aittokallio, Tero ;
Wennerberg, Krister ;
Heckman, Caroline A. ;
Kallioniemi, Olli ;
Porkka, Kimmo .
CANCER DISCOVERY, 2022, 12 (02) :388-401
[10]   Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia [J].
Pemovska, Tea ;
Kontro, Mika ;
Yadav, Bhagwan ;
Edgren, Henrik ;
Eldfors, Samuli ;
Szwajda, Agnieszka ;
Almusa, Henrikki ;
Bespalov, Maxim M. ;
Ellonen, Pekka ;
Elonen, Erkki ;
Gjertsen, Bjorn T. ;
Karjalainen, Riikka ;
Kulesskiy, Evgeny ;
Lagstrom, Sonja ;
Lehto, Anna ;
Lepisto, Maija ;
Lundan, Tuija ;
Majumder, Muntasir Mamun ;
Marti, Jesus M. Lopez ;
Mattila, Pirkko ;
Murumagi, Astrid ;
Mustjoki, Satu ;
Palva, Aino ;
Parsons, Alun ;
Pirttinen, Tero ;
Ramet, Maria E. ;
Suvela, Minna ;
Turunen, Laura ;
Vastrik, Imre ;
Wolf, Maija ;
Knowles, Jonathan ;
Aittokallio, Tero ;
Heckman, Caroline A. ;
Porkka, Kimmo ;
Kallioniemi, Olli ;
Wennerberg, Krister .
CANCER DISCOVERY, 2013, 3 (12) :1416-1429